New insights regarding the regulation of chemotaxis by nucleotides, adenosine, and their receptors

Purinergic Signalling

Volumn 8, Issue 3, 2012, Pages 587-598

  Corriden, Ross ^a   Insel, Paul A ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adenosine; Chemotaxis; Nucleotides; Receptors; Regulation

Indexed keywords

ADENOSINE; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE RECEPTOR; ADENOSINE TRIPHOSPHATE; APYRASE; CHEMOATTRACTANT; CHEMOKINE RECEPTOR CXCR4; ECTO 5' NUCLEOTIDASE; INFLAMMASOME; NUCLEOTIDE; NUCLEOTIDE PYROPHOSPHATASE; PURINERGIC P2 RECEPTOR; PURINERGIC RECEPTOR;

ARTICLE; CANCER CELL; CARCINOGENESIS; CELL MIGRATION; CELL MOTILITY; CHEMOTAXIS; ENDOTHELIUM CELL; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE; MACROPHAGE; MICROGLIA; NEOVASCULARIZATION (PATHOLOGY); NEUTROPHIL; PHAGOCYTE; PHAGOCYTOSIS; SIGNAL TRANSDUCTION; STEM SELL;

ADENOSINE; ADENOSINE TRIPHOSPHATE; ANIMALS; CELL MOVEMENT; CHEMOTAXIS; CHEMOTAXIS, LEUKOCYTE; HUMANS; MICROGLIA; NEOPLASMS; NEUTROPHILS; NUCLEOTIDES; RECEPTORS, CELL SURFACE; RECEPTORS, PURINERGIC P1;

EID: 84861487658     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-012-9311-x     Document Type: Article

References (150)

1. Flannagan RS, Cosio G, Grinstein S (2009) Antimicrobial mechanisms of phagocytes and bacterial evasion strategies. Nat Rev Microbiol 7(5): 355-366. doi: 10. 1038/nrmicro2128.
2. Krause KH (2000) Professional phagocytes: predators and prey of microorganisms. Schweiz Med Wochenschr 130(4): 97-100.
3. Brown EJ (1995) Phagocytosis. Bioessays 17(2): 109-117. doi: 10. 1002/bies. 950170206.
4. Elliott MR, Chekeni FB, Trampont PC, Lazarowski ER, Kadl A, Walk SF, Park D, Woodson RI, Ostankovich M, Sharma P, Lysiak JJ, Harden TK, Leitinger N, Ravichandran KS (2009) Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 461(7261): 282-286.
5. Ravichandran KS (2010) Find-me and eat-me signals in apoptotic cell clearance: progress and conundrums. J Exp Med 207(9): 1807-1817. doi: 10. 1084/jem. 20101157.
6. Junger WG (2011) Immune cell regulation by autocrine purinergic signalling. Nat Rev Immunol 11(3): 201-212. doi: 10. 1038/nri2938.
7. Linden J (2011) Regulation of leukocyte function by adenosine receptors. Adv Pharmacol 61: 95-114. doi: 10. 1016/B978-0-12-385526-8. 00004-7.
8. Iglesias PA, Devreotes PN (2008) Navigating through models of chemotaxis. Curr Opin Cell Biol 20(1): 35-40.
9. Patlak C (1953) Random walk with persistence and external bias. Bull Math Biol 15(3): 311-338. doi: 10. 1007/bf02476407.
10. Bosgraaf L, van Haastert PJM (2009) The ordered extension of pseudopodia by amoeboid cells in the absence of external cues. PLoS One 4(4): e5253.
11. Petrie RJ, Doyle AD, Yamada KM (2009) Random versus directionally persistent cell migration. Nat Rev Mol Cell Biol 10(8): 538-549.
12. Lazarowski E (2012) Vesicular and conductive mechanisms of nucleotide release. Purinergic Signalling. doi: 10. 1007/s11302-012-9304-9.
13. McDonald B, Pittman K, Menezes GB, Hirota SA, Slaba I, Waterhouse CCM, Beck PL, Muruve DA, Kubes P (2010) Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science 330 (6002): 362-366. doi: 10. 1126/science. 1195491.
14. Isfort K, Ebert F, Bornhorst J, Sargin S, Kardakaris R, Pasparakis M, Baehler M, Schwerdtle T, Schwab A, Hanley PJ (2011) Real-time imaging reveals that P2Y2 and P2Y12 receptor agonists are not chemoattractants and macrophage chemotaxis to C5a is PI3K- and p38 MAPK-independent. J Biol Chem. doi: 10. 1074/jbc. M111. 289793.
15. Surprenant A, North RA (2009) Signaling at purinergic P2X receptors. Annu Rev Physiol 71(1): 333-359. doi: 10. 1146/annurev. physiol. 70. 113006. 100630.
16. von Kugelgen I, Harden TK (2011) Molecular pharmacology, physiology, and structure of the P2Y receptors. Adv Pharmacol 61: 373-415. doi: 10. 1016/B978-0-12-385526-8. 00012-6.
17. Zimmermann H (2000) Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedebergs Arch Pharmacol 362(4-5): 299-309.
18. Fredholm BB, Ijzerman AP, Jacobson KA, Linden J, Muller CE (2011) International union of basic and clinical pharmacology. LXXXI. Nomenclature and classification of adenosine receptors-an update. Pharmacol Rev 63(1): 1-34. doi: 10. 1124/pr. 110. 003285.
19. Young JD, Yao SY, Sun L, Cass CE, Baldwin SA (2008) Human equilibrative nucleoside transporter (ENT) family of nucleoside and nucleobase transporter proteins. Xenobiotica 38(7-8): 995-1021. doi: 10. 1080/00498250801927427.
20. Sager G, Ravna AW (2009) Cellular efflux of cAMP and cGMP-a question about selectivity. Mini Rev Med Chem 9(8): 1009-1013.
21. Bader S, Kortholt A, van Haastert PJM (2007) Seven dictyostelium discoideum phosphodiesterases degrade three pools of cAMP and cGMP. Biochem J 402(1): 153-161. doi: 10. 1042/bj20061153.
22. Rosenberg PA, Dichter MA (1989) Extracellular cAMP accumulation and degradation in rat cerebral cortex in dissociated cell culture. J Neurosci 9(8): 2654-2663.
23. Jackson EK, Mi Z, Dubey RK (2007) The extracellular cAMP-adenosine pathway significantly contributes to the in vivo production of adenosine. J Pharmacol Exp Ther 320(1): 117-123. doi: 10. 1124/jpet. 106. 112748.
24. Di Virgilio F (2007) Liaisons dangereuses: P2X(7) and the inflammasome. Trends Pharmacol Sci 28(9): 465-472. doi: 10. 1016/j. tips. 2007. 07. 002.
25. Martinon F, Gaide O, Pétrilli V, Mayor A, Tschopp J (2007) NALP inflammasomes: a central role in innate immunity. Semin Immunopathol 29(3): 213-229. doi: 10. 1007/s00281-007-0079-y.
26. Jandl JH (1996) Blood: textbook of hematology. Boston, Little Brown and Co.
27. Bagorda A, Parent CA (2008) Eukaryotic chemotaxis at a glance. J Cell Sci 121(16): 2621-2624. doi: 10. 1242/jcs. 018077.
28. Zigmond SH (1977) Ability of polymorphonuclear leukocytes to orient in gradients of chemotactic factors. J Cell Biol 75(2 Pt 1): 606-616.
29. Chen Y, Corriden R, Inoue Y, Yip L, Hashiguchi N, Zinkernagel A, Nizet V, Insel PA, Junger WG (2006) ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. Science 314(5806): 1792-1795. doi: 10. 1126/science. 1132559.
30. Lecut C, Frederix K, Johnson DM, Deroanne C, Thiry M, Cl F, Maree Rl, Evans RJ, Volders PGA, Bours V, Oury Cc (2009) P2X1 ion channels promote neutrophil chemotaxis through rho kinase activation. J Immunol 183(4): 2801-2809. doi: 10. 4049/jimmunol. 0804007.
31. He R, Tan L, Browning DD, Wang JM, Ye RD (2000) The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met is a potent chemotactic agonist for mouse formyl peptide receptor. J Immunol 165(8): 4598-4605.
32. Kronlage M, Song J, Sorokin L, Isfort K, Schwerdtle T, Leipziger J, Robaye B, Conley PB, Kim H-C, Sargin S, Schon P, Schwab A, Hanley PJ (2010) Autocrine purinergic receptor signaling is essential for macrophage chemotaxis. Sci Signal 3(132): ra55. doi: 10. 1126/scisignal. 2000588.
33. Jr R, Vollmer I, Stark S, Wagner R, Ngamsri K-C, Eltzschig HK (2009) Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs. FASEB J 23(2): 473-482. doi: 10. 1096/fj. 08-119701.
34. Corriden R, Insel PA, Junger WG (2007) A novel method using fluorescence microscopy for real-time assessment of ATP release from individual cells. Am J Physiol Cell Physiol 293(4): C1420-C1425. doi: 10. 1152/ajpcell. 00271. 2007.
35. Inoue Y, Chen Y, Hirsh MI, Yip L, Junger WG (2008) A3 and P2Y2 receptors control the recruitment of neutrophils to the lungs in a mouse model of sepsis. Shock 30(2): 173-177. doi: 10. 1097/shk. 0b013e318160dad4.
36. Chen Y, Yao Y, Sumi Y, Li A, To UK, Elkhal A, Inoue Y, Woehrle T, Zhang Q, Hauser C, Junger WG (2010) Purinergic signaling: a fundamental mechanism in neutrophil activation. Sci Signal 3 (125): ra45-. doi: 10. 1126/scisignal. 2000549.
37. Kukulski F, Ben Yebdri F, Lecka J, Kauffenstein G, Levesque SA, Martín-Satué M, Sévigny J (2009) Extracellular ATP and P2 receptors are required for IL-8 to induce neutrophil migration. Cytokine 46(2): 166-170.
38. Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J (2001) International union of pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53(4): 527-552.
39. Koizumi S, Odashima M, Otaka M, Jin M, Linden J, Watanabe S, Ohnishi H (2009) Attenuation of gastric mucosal inflammation induced by indomethacin through activation of the A2A adenosine receptor in rats. J Gastroenterol 44(5): 419-425. doi: 10. 1007/s00535-009-0028-8.
40. Wang H, Zhang W, Tang R, Zhu C, Bucher C, Blazar BR, Geng JG, Zhang C, Linden J, Wu C, Huo Y (2010) Adenosine receptor A2A deficiency in leukocytes increases arterial neointima formation in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 30(5): 915-922. doi: 10. 1161/ATVBAHA. 109. 202572.
41. Neely CF, Jin J, Keith IM (1997) A1-adenosine receptor antagonists block endotoxin-induced lung injury. Am J Physiol 272(2 Pt 1): L353-L361.
42. Cronstein BN, Levin RI, Philips M, Hirschhorn R, Abramson SB, Weissmann G (1992) Neutrophil adherence to endothelium is enhanced via adenosine A1 receptors and inhibited via adenosine A2 receptors. J Immunol 148(7): 2201-2206.
43. Ngamsri KC, Wagner R, Vollmer I, Stark S, Reutershan J (2010) Adenosine receptor A1 regulates polymorphonuclear cell trafficking and microvascular permeability in lipopolysaccharide-induced lung injury. J Immunol 185(7): 4374-4384. doi: 10. 4049/jimmunol. 1000433.
44. van der Hoeven D, Wan TC, Auchampach JA (2008) Activation of the A(3) adenosine receptor suppresses superoxide production and chemotaxis of mouse bone marrow neutrophils. Mol Pharmacol 74(3): 685-696. doi: 10. 1124/mol. 108. 048066.
45. Wagner R, Ngamsri K-C, Stark S, Vollmer I, Jr R (2010) Adenosine receptor A3 is a critical mediator in LPS-induced pulmonary inflammation. Am J Physiol Lung Cell Mol Physiol 299(4): L502-L512. doi: 10. 1152/ajplung. 00083. 2010.
46. van der Hoeven D, Gizewski ET, Auchampach JA (2010) Activation of the A(3) adenosine receptor inhibits fMLP-induced Rac activation in mouse bone marrow neutrophils. Biochem Pharmacol 79(11): 1667-1673. doi: 10. 1016/j. bcp. 2010. 02. 002.
47. Corriden R, Chen Y, Inoue Y, Beldi G, Robson SC, Insel PA, Junger WG (2008) Ecto-nucleoside triphosphate diphosphohydrolase 1 (E-NTPDase1/CD39) regulates neutrophil chemotaxis by hydrolyzing released ATP to adenosine. J Biol Chem 283(42): 28480-28486. doi: 10. 1074/jbc. M800039200.
48. Kettenmann H, Hanisch UK, Noda M, Verkhratsky A (2011) Physiology of microglia. Physiol Rev 91(2): 461-553. doi: 10. 1152/physrev. 00011. 2010.
49. Neary JT, Baker L, Jorgensen SL, Norenberg MD (1994) Extracellular ATP induces stellation and increases glial fibrillary acidic protein content and DNA synthesis in primary astrocyte cultures. Acta Neuropathol 87(1): 8-13.
50. Honda S, Sasaki Y, Ohsawa K, Imai Y, Nakamura Y, Inoue K, Kohsaka S (2001) Extracellular ATP or ADP induce chemotaxis of cultured microglia through Gi/o-coupled P2Y receptors. J Neurosci 21(6): 1975-1982.
51. Kurpius D, Nolley EP, Dailey ME (2007) Purines induce directed migration and rapid homing of microglia to injured pyramidal neurons in developing hippocampus. Glia 55(8): 873-884. doi: 10. 1002/glia. 20509.
52. Duan Y, Sahley CL, Muller KJ (2009) ATP and NO dually control migration of microglia to nerve lesions. Dev Neurobiol 69(1): 60-72. doi: 10. 1002/dneu. 20689.
53. Miller AM, Stella N (2009) Microglial cell migration stimulated by ATP and C5a involve distinct molecular mechanisms: quantification of migration by a novel near-infrared method. Glia 57(8): 875-883. doi: 10. 1002/glia. 20813.
54. Choi M, Cho K, Shin S, Ko H, Kwon K, Shin C, Ko K (2010) ATP induced microglial cell migration through non-transcriptional activation of matrix metalloproteinase-9. Arch Pharm Res 33(2): 257-265. doi: 10. 1007/s12272-010-0211-8.
55. Lambert C, Ase AR, Seguela P, Antel JP (2010) Distinct migratory and cytokine responses of human microglia and macrophages to ATP. Brain Behav Immun 24(8): 1241-1248. doi: 10. 1016/j. bbi. 2010. 02. 010.
56. Samuels SE, Lipitz JB, Dahl G, Muller KJ (2010) Neuroglial ATP release through innexin channels controls microglial cell movement to a nerve injury. J Gen Physiol 136(4): 425-442. doi: 10. 1085/jgp. 201010476.
57. Haynes SE, Hollopeter G, Yang G, Kurpius D, Dailey ME, Gan WB, Julius D (2006) The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat Neurosci 9(12): 1512-1519. doi: 10. 1038/nn1805.
58. De Simone R, Niturad CE, De Nuccio C, Ajmone-Cat MA, Visentin S, Minghetti L (2010) TGF-β and LPS modulate ADP-induced migration of microglial cells through P2Y1 and P2Y12 receptor expression. J Neurochem 115(2): 450-459. doi: 10. 1111/j. 1471-4159. 2010. 06937. x.
59. Horvath RJ, DeLeo JA (2009) Morphine enhances microglial migration through modulation of P2X4 receptor signaling. J Neurosci 29(4): 998-1005. doi: 10. 1523/jneurosci. 4595-08. 2009.
60. Ifuku M, Farber K, Okuno Y, Yamakawa Y, Miyamoto T, Nolte C, Merrino VF, Kita S, Iwamoto T, Komuro I, Wang B, Cheung G, Ishikawa E, Ooboshi H, Bader M, Wada K, Kettenmann H, Noda M (2007) Bradykinin-induced microglial migration mediated by B1-bradykinin receptors depends on Ca2+ influx via reverse-mode activity of the Na+/Ca2+ exchanger. J Neurosci 27(48): 13065-13073. doi: 10. 1523/JNEUROSCI. 3467-07. 2007.
61. Cudaback E, Li X, Montine KS, Montine TJ, Keene CD (2011) Apolipoprotein E isoform-dependent microglia migration. FASEB J 25(6): 2082-2091. doi: 10. 1096/fj. 10-176891.
62. Orr AG, Orr AL, Li XJ, Gross RE, Traynelis SF (2009) Adenosine A(2A) receptor mediates microglial process retraction. Nat Neurosci 12(7): 872-878. doi: 10. 1038/nn. 2341.
63. van der Putten C, Zuiderwijk-Sick EA, van Straalen L, de Geus ED, Boven LA, Kondova I, Ijzerman AP, Bajramovic JJ (2009) Differential expression of adenosine A3 receptors controls adenosine A2A receptor-mediated inhibition of TLR responses in microglia. J Immunol 182(12): 7603-7612. doi: 10. 4049/jimmunol. 0803383.
64. Bernascone S, Erriquez J, Ferraro M, Genazzani AA, Distasi C (2010) Novel adenosine and cAMP signalling pathways in migrating glial cells. Cell Calcium 48 (1): 83-90.
65. Choi I-Y, Lee J-C, Ju C, Hwang S, Cho G-S, Lee HW, Choi WJ, Jeong LS, Kim W-K (2011) A3 adenosine receptor agonist reduces brain ischemic injury and inhibits inflammatory cell migration in rats. Am J Pathol 179 (4): 2042-2052.
66. Braun N, Sevigny J, Robson SC, Enjyoji K, Guckelberger O, Hammer K, Di Virgilio F, Zimmermann H (2000) Assignment of ecto-nucleoside triphosphate diphosphohydrolase-1/cd39 expression to microglia and vasculature of the brain. Eur J Neurosci 12(12): 4357-4366.
67. Nedeljkovic N, Bjelobaba I, Subasic S, Lavrnja I, Pekovic S, Stojkov D, Vjestica A, Rakic L, Stojiljkovic M (2006) Up-regulation of ectonucleotidase activity after cortical stab injury in rats. Cell Biol Int 30(6): 541-546. doi: 10. 1016/j. cellbi. 2006. 03. 001.
68. Farber K, Markworth S, Pannasch U, Nolte C, Prinz V, Kronenberg G, Gertz K, Endres M, Bechmann I, Enjyoji K, Robson SC, Kettenmann H (2008) The ectonucleotidase cd39/ENTPDase1 modulates purinergic-mediated microglial migration. Glia 56(3): 331-341. doi: 10. 1002/glia. 20606.
69. Avignone E, Ulmann L, Levavasseur F, Rassendren F, Audinat E (2008) Status epilepticus induces a particular microglial activation state characterized by enhanced purinergic signaling. J Neurosci 28(37): 9133-9144. doi: 10. 1523/JNEUROSCI. 1820-08. 2008.
70. Folkman J (2006) Angiogenesis. Annu Rev Med 57(1): 1-18. doi: 10. 1146/annurev. med. 57. 121304. 131306.
71. Shen J, DiCorleto PE (2008) ADP stimulates human endothelial cell migration via P2Y1 nucleotide receptor-mediated mitogen-activated protein kinase pathways. Circ Res 102(4): 448-456. doi: 10. 1161/CIRCRESAHA. 107. 165795.
72. Yokdang N, Tellez JD, Tian H, Norvell J, Barsky SH, Valencik M, Buxton IL (2011) A role for nucleotides in support of breast cancer angiogenesis: heterologous receptor signalling. Br J Cancer 104(10): 1628-1640. doi: 10. 1038/bjc. 2011. 134.
73. Gerasimovskaya E, Woodward H, Tucker D, Stenmark K (2008) Extracellular ATP is a pro-angiogenic factor for pulmonary artery vasa vasorum endothelial cells. Angiogenesis 11(2): 169-182. doi: 10. 1007/s10456-007-9087-8.
74. Roedersheimer M, Nijmeh H, Burns N, Sidiakova AA, Stenmark KR, Gerasimovskaya EV (2011) Complementary effects of extracellular nucleotides and platelet-derived extracts on angiogenesis of vasa vasorum endothelial cells in vitro and subcutaneous Matrigel plugs in vivo. Vasc Cell 3(1): 4. doi: 10. 1186/2045-824X-3-4.
75. Koyama T, Kimura C, Hayashi M, Watanabe M, Karashima Y, Oike M (2009) Hypergravity induces ATP release and actin reorganization via tyrosine phosphorylation and RhoA activation in bovine endothelial cells. Pflugers Arch 457(4): 711-719. doi: 10. 1007/s00424-008-0544-z.
76. Kaczmarek E, Erb L, Koziak K, Jarzyna R, Wink MR, Guckelberger O, Blusztajn JK, Trinkaus-Randall V, Weisman GA, Robson SC (2005) Modulation of endothelial cell migration by extracellular nucleotides: involvement of focal adhesion kinase and phosphatidylinositol 3-kinase-mediated pathways. Thromb Haemost 93(4): 735-742. doi: 10. 1267/THRO05040735.
77. Woodward HN, Anwar A, Riddle S, Taraseviciene-Stewart L, Fragoso M, Stenmark KR, Gerasimovskaya EV (2009) PI3K, Rho, and ROCK play a key role in hypoxia-induced ATP release and ATP-stimulated angiogenic responses in pulmonary artery vasa vasorum endothelial cells. Am J Physiol Lung Cell Mol Physiol 297(5): L954-L964. doi: 10. 1152/ajplung. 00038. 2009.
78. Quillen EE, Haslam GC, Samra HS, Amani-Taleshi D, Knight JA, Wyatt DE, Bishop SC, Colvert KK, Richter ML, Kitos PA (2006) Ectoadenylate kinase and plasma membrane ATP synthase activities of human vascular endothelial cells. J Biol Chem 281(30): 20728-20737. doi: 10. 1074/jbc. M513042200.
79. Zhang X, Gao F, L-l Yu, Peng Y, H-h L, J-y L, Yin M, Ni J (2008) Dual functions of a monoclonal antibody against cell surface F1F0 ATP synthase on both HUVEC and tumor cells1. Acta Pharmacol Sin 29(8): 942-950. doi: 10. 1111/j. 1745-7254. 2008. 00830. x.
80. Notari L, Arakaki N, Mueller D, Meier S, Amaral J, Becerra SP (2010) Pigment epithelium-derived factor binds to cell-surface F(1)-ATP synthase. FEBS J 277(9): 2192-2205. doi: 10. 1111/j. 1742-4658. 2010. 07641. x.
81. Freeman KW, Bowman BR, Zetter BR (2011) Regenerative protein thymosin Œ ≤ -4 is a novel regulator of purinergic signaling. FASEB J 25(3): 907-915. doi: 10. 1096/fj. 10-169417.
82. Moser TL, Stack MS, Asplin I, Enghild JJ, Hojrup P, Everitt L, Hubchak S, Schnaper HW, Pizzo SV (1999) Angiostatin binds ATP synthase on the surface of human endothelial cells. Proc Natl Acad Sci USA 96(6): 2811-2816.
83. Muller T, Robaye B, Vieira RP, Ferrari D, Grimm M, Jakob T, Martin SF, Di Virgilio F, Boeynaems JM, Virchow JC, Idzko M (2010) The purinergic receptor P2Y2 receptor mediates chemotaxis of dendritic cells and eosinophils in allergic lung inflammation. Allergy 65(12): 1545-1553. doi: 10. 1111/j. 1398-9995. 2010. 02426. x.
84. Slater M, Danieletto S, Pooley M, Cheng Teh L, Gidley-Baird A, Barden JA (2004) Differentiation between cancerous and normal hyperplastic lobules in breast lesions. Breast Cancer Res Treat 83(1): 1-10. doi: 10. 1023/B: BREA. 0000010670. 85915. 0f.
85. Slater M, Danieletto S, Gidley-Baird A, Teh LC, Barden JA (2004) Early prostate cancer detected using expression of non-functional cytolytic P2X7 receptors. Histopathology 44(3): 206-215. doi: 10. 1111/j. 0309-0167. 2004. 01798. x.
86. Adinolfi E, Melchiorri L, Falzoni S, Chiozzi P, Morelli A, Tieghi A, Cuneo A, Castoldi G, Di Virgilio F, Baricordi OR (2002) P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia. Blood 99(2): 706-708.
87. Solini A, Cuccato S, Ferrari D, Santini E, Gulinelli S, Callegari MG, Dardano A, Faviana P, Madec S, Di Virgilio F, Monzani F (2008) Increased P2X7 receptor expression and function in thyroid papillary cancer: a new potential marker of the disease? Endocrinology 149(1): 389-396. doi: 10. 1210/en. 2007-1223.
88. Wei W, Ryu JK, Choi HB, McLarnon JG (2008) Expression and function of the P2X(7) receptor in rat C6 glioma cells. Cancer Lett 260(1-2): 79-87. doi: 10. 1016/j. canlet. 2007. 10. 025.
89. Jelassi B, Chantome A, Alcaraz-Perez F, Baroja-Mazo A, Cayuela ML, Pelegrin P, Surprenant A, Roger S (2011) P2X(7) receptor activation enhances SK3 channels- and cystein cathepsin-dependent cancer cells invasiveness. Oncogene 30(18): 2108-2122. doi: 10. 1038/onc. 2010. 593.
90. Miki K, Tanaka H, Nagai Y, Kimura C, Oike M (2010) Transforming growth factor β1 alters calcium mobilizing properties and endogenous ATP release in A549 cells: possible implications for cell migration. J Pharmacol Sci: 1007220420. doi: 10. 1254/jphs. 10124FP.
91. Chi SL, Wahl ML, Mowery YM, Shan S, Mukhopadhyay S, Hilderbrand SC, Kenan DJ, Lipes BD, Johnson CE, Marusich MF, Capaldi RA, Dewhirst MW, Pizzo SV (2007) Angiostatin-like activity of a monoclonal antibody to the catalytic subunit of F1F0 ATP synthase. Cancer Res 67(10): 4716-4724. doi: 10. 1158/0008-5472. CAN-06-1094.
92. Wang L, Zhou X, Zhou T, Ma D, Chen S, Zhi X, Yin L, Shao Z, Ou Z, Zhou P (2008) Ecto-5′-nucleotidase promotes invasion, migration and adhesion of human breast cancer cells. J Cancer Res Clin Oncol 134(3): 365-372. doi: 10. 1007/s00432-007-0292-z.
93. Stagg J, Divisekera U, McLaughlin N, Sharkey J, Pommey S, Denoyer D, Dwyer KM, Smyth MJ (2010) Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis. Proc Natl Acad Sci U S A 107(4): 1547-1552. doi: 10. 1073/pnas. 0908801107.
94. Richard CL, Tan EY, Blay J (2006) Adenosine upregulates CXCR4 and enhances the proliferative and migratory responses of human carcinoma cells to CXCL12/SDF-1α. Int J Cancer 119(9): 2044-2053. doi: 10. 1002/ijc. 22084.
95. Stracke ML, Krutzsch HC, Unsworth EJ, Arestad A, Cioce V, Schiffmann E, Liotta LA (1992) Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. J Biol Chem 267(4): 2524-2529.
96. Ptaszynska MM, Pendrak ML, Stracke ML, Roberts DD (2010) Autotaxin signaling via lysophosphatidic acid receptors contributes to vascular endothelial growth factor-induced endothelial cell migration. Mol Cancer Res 8(3): 309-321. doi: 10. 1158/1541-7786. MCR-09-0288.
97. Panupinthu N, Lee HY, Mills GB (2010) Lysophosphatidic acid production and action: critical new players in breast cancer initiation and progression. Br J Cancer 102(6): 941-946. doi: 10. 1038/sj. bjc. 6605588.
98. Hirakawa M, Oike M, Karashima Y, Ito Y (2004) Sequential activation of RhoA and FAK/paxillin leads to ATP release and actin reorganization in human endothelium. J Physiol 558(Pt 2): 479-488. doi: 10. 1113/jphysiol. 2004. 065334jphysiol. 2004. 065334.
99. Roussos ET, Condeelis JS, Patsialou A (2011) Chemotaxis in cancer. Nat Rev Cancer 11 (8): 573-587.
100. Quezada SA, Peggs KS, Simpson TR, Allison JP (2011) Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication. Immunol Rev 241 (1): 104-118. doi: 10. 1111/j. 1600-065X. 2011. 01007. x.
101. Schuster M, Nechansky A, Kircheis R (2006) Cancer immunotherapy. Biotechnol J 1(2): 138-147. doi: 10. 1002/biot. 200500044.
102. Barreiro O, Martin P, Gonzalez-Amaro R, Sanchez-Madrid F (2010) Molecular cues guiding inflammatory responses. Cardiovasc Res 86(2): 174-182. doi: 10. 1093/cvr/cvq001.
103. Birmingham JM, Busik JV, Hansen-Smith FM, Fenton JI (2009) Novel mechanism for obesity-induced colon cancer progression. Carcinogenesis 30(4): 690-697. doi: 10. 1093/carcin/bgp041.
104. Velnar T, Bailey T, Smrkolj V (2009) The wound healing process: an overview of the cellular and molecular mechanisms. J Int Med Res 37(5): 1528-1542.
105. Aman A, Piotrowski T (2010) Cell migration during morphogenesis. Dev Biol 341(1): 20-33.
106. Chung WC, Kermode JC (2005) Suramin disrupts receptor-G protein coupling by blocking association of G protein alpha and betagamma subunits. J Pharmacol Exp Ther 313(1): 191-198. doi: 10. 1124/jpet. 104. 078311.
107. Feng Y, Li M, Wang B, Zheng YG (2010) Discovery and mechanistic study of a class of protein arginine methylation inhibitors. J Med Chem 53(16): 6028-6039. doi: 10. 1021/jm100416n.
108. Zengel P, Nguyen-Hoang A, Schildhammer C, Zantl R, Kahl V, Horn E (2011) mu-Slide chemotaxis: a new chamber for long-term chemotaxis studies. BMC Cell Biol 12(1): 21. doi: 10. 1186/1471-2121-12-21.
109. Zigmond SH, Foxman EF, Segall JE (2001) Chemotaxis assays for eukaryotic cells. In: Current protocols in cell biology. John Wiley & Sons, Inc. doi: 10. 1002/0471143030. cb1201s00.
110. Seror C, Melki MT, Subra F, Raza SQ, Bras M, Saidi H, Nardacci R, Voisin L, Paoletti A, Law F, Martins I, Amendola A, Abdul-Sater AA, Ciccosanti F, Delelis O, Niedergang F, Thierry S, Said-Sadier N, Lamaze C, Metivier D, Estaquier J, Fimia GM, Falasca L, Casetti R, Modjtahedi N, Kanellopoulos J, Mouscadet JF, Ojcius DM, Piacentini M, Gougeon ML, Kroemer G, Perfettini JL (2011) Extracellular ATP acts on P2Y2 purinergic receptors to facilitate HIV-1 infection. J Exp Med 208(9): 1823-1834. doi: 10. 1084/jem. 20101805.
111. Tanneur V, Duranton C, Brand VB, Sandu CD, Akkaya C, Kasinathan RS, Gachet C, Sluyter R, Barden JA, Wiley JS, Lang F, Huber SM (2006) Purinoceptors are involved in the induction of an osmolyte permeability in malaria-infected and oxidized human erythrocytes. FASEB J 20(1): 133-135. doi: 10. 1096/fj. 04-3371fje.
112. Mackay CR (2008) Moving targets: cell migration inhibitors as new anti-inflammatory therapies. Nat Immunol 9(9): 988-998.
113. Striedinger K, Meda P, Scemes E (2007) Exocytosis of ATP from astrocyte progenitors modulates spontaneous Ca2+ oscillations and cell migration. Glia 55(6): 652-662. doi: 10. 1002/glia. 20494.
114. Braun OO, Lu D, Aroonsakool N, Insel PA (2010) Uridine triphosphate (UTP) induces profibrotic responses in cardiac fibroblasts by activation of P2Y2 receptors. J Mol Cell Cardiol 49(3): 362-369. doi: 10. 1016/j. yjmcc. 2010. 05. 001.
115. Mayo C, Ren R, Rich C, Stepp MA, Trinkaus-Randall V (2008) Regulation by P2X7: epithelial migration and stromal organization in the cornea. Invest Ophthalmol Vis Sci 49(10): 4384-4391. doi: 10. 1167/iovs. 08-1688.
116. Crooke A, Mediero A, Guzman-Aranguez A, Pintor J (2009) Silencing of P2Y2 receptor delays Ap4A-corneal re-epithelialization process. Mol Vis 15: 1169-1178.
117. Boucher I, Rich C, Lee A, Marcincin M, Trinkaus-Randall V (2010) The P2Y2 receptor mediates the epithelial injury response and cell migration. Am J Physiol Cell Physiol 299(2): C411-C421. doi: 10. 1152/ajpcell. 00100. 2009.
118. Vanderstocken G, Bondue B, Horckmans M, Di Pietrantonio L, Robaye B, Boeynaems JM, Communi D (2010) P2Y2 receptor regulates VCAM-1 membrane and soluble forms and eosinophil accumulation during lung inflammation. J Immunol 185(6): 3702-3707. doi: 10. 4049/jimmunol. 0903908.
119. Kobayashi T, Kouzaki H, Kita H (2010) Human eosinophils recognize endogenous danger signal crystalline uric acid and produce proinflammatory cytokines mediated by autocrine ATP. J Immunol 184(11): 6350-6358. doi: 10. 4049/jimmunol. 0902673.
120. Hess CN, Kou R, Johnson RP, Li GK, Michel T (2009) ADP signaling in vascular endothelial cells. J Biol Chem 284(47): 32209-32224. doi: 10. 1074/jbc. M109. 032656.
121. Tagami M, Kusuhara S, Imai H, Uemura A, Honda S, Tsukahara Y, Negi A (2010) MRP4 knockdown enhances migration, suppresses apoptosis, and produces aggregated morphology in human retinal vascular endothelial cells. Biochem Biophys Res Commun 400(4): 593-598. doi: 10. 1016/j. bbrc. 2010. 08. 109.
122. Rossi L, Manfredini R, Bertolini F, Ferrari D, Fogli M, Zini R, Salati S, Salvestrini V, Gulinelli S, Adinolfi E, Ferrari S, Di Virgilio F, Baccarani M, Lemoli RM (2007) The extracellular nucleotide UTP is a potent inducer of hematopoietic stem cell migration. Blood 109(2): 533-542. doi: 10. 1182/blood-2006-01-035634.
123. Hashmi AZ, Hakim W, Kruglov EA, Watanabe A, Watkins W, Dranoff JA, Mehal WZ (2007) Adenosine inhibits cytosolic calcium signals and chemotaxis in hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol 292(1): G395-G401. doi: 10. 1152/ajpgi. 00208. 2006.
124. Andrade CM, Lopez PL, Noronha BT, Wink MR, Borojevic R, Margis R, Lenz G, Battastini AM, Guma FC (2011) Ecto-5′-nucleotidase/CD73 knockdown increases cell migration and mRNA level of collagen I in a hepatic stellate cell line. Cell Tissue Res 344(2): 279-286. doi: 10. 1007/s00441-011-1140-7.
125. Giltaire S, Lambert S, Poumay Y (2011) HB-EGF synthesis and release induced by cholesterol depletion of human epidermal keratinocytes is controlled by extracellular atp and involves both p38 and ERK1/2 signaling pathways. J Cell Physiol 226(6): 1651-1659. doi: 10. 1002/jcp. 22496.
126. Taboubi S, Milanini J, Delamarre E, Parat F, Garrouste F, Pommier G, Takasaki J, Hubaud JC, Kovacic H, Lehmann M (2007) G alpha(q/11)-coupled P2Y2 nucleotide receptor inhibits human keratinocyte spreading and migration. FASEB J 21(14): 4047-4058. doi: 10. 1096/fj. 06-7476com.
127. Taboubi S, Garrouste F, Parat F, Pommier G, Faure E, Monferran S, Kovacic H, Lehmann M (2010) Gq-coupled purinergic receptors inhibit insulin-like growth factor-I/phosphoinositide 3-kinase pathway-dependent keratinocyte migration. Mol Biol Cell 21(6): 946-955. doi: 10. 1091/mbc. E09-06-0497.
128. Lin C, Ren S, Zhang L, Jin H, Sun J, Zuo Y (2011) Extracellular ATP induces CD44 shedding from macrophage-like P388D1 cells via the P2X7 receptor. Hematol Oncol. doi: 10. 1002/hon. 1008.
129. Martins JP, Silva RB, Coutinho-Silva R, Takiya CM, Battastini AM, Morrone FB, Campos MM (2011) P2X7 purinergic receptor and its role in inflammatory and nociceptive alterations associated to cyclophosphamide-induced hemorrhagic cystitis in mice. Br J Pharmacol. doi: 10. 1111/j. 1476-5381. 2011. 01535. x.
130. Koroskenyi K, Duro E, Pallai A, Sarang Z, Kloor D, Ucker DS, Beceiro S, Castrillo A, Chawla A, Ledent CA, Fesus L, Szondy Z (2011) Involvement of adenosine A2A receptors in engulfment-dependent apoptotic cell suppression of inflammation. J Immunol 186(12): 7144-7155. doi: 10. 4049/jimmunol. 1002284.
131. Williams AJ, Cronstein BN (2011) The Effect of A(2A) adenosine receptor activation on C-C chemokine receptor 7 expression in human THP1 macrophages during inflammation. Inflammation. doi: 10. 1007/s10753-011-9353-1.
132. Ode A, Kopf J, Kurtz A, Schmidt-Bleek K, Schrade P, Kolar P, Buttgereit F, Lehmann K, Hutmacher DW, Duda GN, Kasper G (2011) CD73 and CD29 concurrently mediate the mechanically induced decrease of migratory capacity of mesenchymal stromal cells. Eur Cell Mater 22: 26-42.
133. Ohsawa K, Irino Y, Nakamura Y, Akazawa C, Inoue K, Kohsaka S (2007) Involvement of P2X4 and P2Y12 receptors in ATP-induced microglial chemotaxis. Glia 55(6): 604-616. doi: 10. 1002/glia. 20489.
134. Ben Yebdri F, Kukulski F, Tremblay A, Sévigny J (2009) Concomitant activation of P2Y2 and P2Y6 receptors on monocytes is required for TLR1/2-induced neutrophil migration by regulating IL-8 secretion. Eur J Immunol 39(10): 2885-2894. doi: 10. 1002/eji. 200939347.
135. Gorini S, Callegari G, Romagnoli G, Mammi C, Mavilio D, Rosano G, Fini M, Di Virgilio F, Gulinelli S, Falzoni S, Cavani A, Ferrari D, la Sala A (2010) ATP secreted by endothelial cells blocks CXCL 1-elicited natural killer cell chemotaxis and cytotoxicity via P2Y receptor activation. Blood 116(22): 4492-4500. doi: 10. 1182/blood-2009-12-260828.
136. Liu X, Hashimoto-Torii K, Torii M, Haydar TF, Rakic P (2008) The role of ATP signaling in the migration of intermediate neuronal progenitors to the neocortical subventricular zone. Proc Natl Acad Sci USA 105(33): 11802-11807. doi: 10. 1073/pnas. 0805180105.
137. Grimm I, Ullsperger SN, Zimmermann H (2010) Nucleotides and epidermal growth factor induce parallel cytoskeletal rearrangements and migration in cultured adult murine neural stem cells. Acta Physiol (Oxf) 199(2): 181-189. doi: 10. 1111/j. 1748-1716. 2010. 02092. x.
138. Kukulski F, Ben Yebdri F, Bahrami F, Levesque SA, Martin-Satue M, Sevigny J (2010) The P2 receptor antagonist PPADS abrogates LPS-induced neutrophil migration in the murine air pouch via inhibition of MIP-2 and KC production. Mol Immunol 47(4): 833-839. doi: 10. 1016/j. molimm. 2009. 09. 037.
139. Hyman MC, Petrovic-Djergovic D, Visovatti SH, Liao H, Yanamadala S, Bouis D, Su EJ, Lawrence DA, Broekman MJ, Marcus AJ, Pinsky DJ (2009) Self-regulation of inflammatory cell trafficking in mice by the leukocyte surface apyrase CD39. J Clin Invest 119(5): 1136-1149. doi: 10. 1172/JCI36433.
140. Reutershan J, Cagnina RE, Chang D, Linden J, Ley K (2007) Therapeutic anti-inflammatory effects of myeloid cell adenosine receptor A2a stimulation in lipopolysaccharide-induced lung injury. J Immunol 179(2): 1254-1263.
141. Ando K, Obara Y, Sugama J, Kotani A, Koike N, Ohkubo S, Nakahata N (2010) P2Y2 receptor-Gq/11 signaling at lipid rafts is required for UTP-induced cell migration in NG 108-15 cells. J Pharmacol Exp Ther. doi: 10. 1124/jpet. 110. 167528.
142. Agresti C, Meomartini ME, Amadio S, Ambrosini E, Serafini B, Franchini L, Volonte C, Aloisi F, Visentin S (2005) Metabotropic P2 receptor activation regulates oligodendrocyte progenitor migration and development. Glia 50(2): 132-144. doi: 10. 1002/glia. 20160.
143. Omatsu-Kanbe M, Inoue K, Fujii Y, Yamamoto T, Isono T, Fujita N, Matsuura H (2006) Effect of ATP on preadipocyte migration and adipocyte differentiation by activating P2Y receptors in 3T3-L1 cells. Biochem J 393(Pt 1): 171-180. doi: 10. 1042/BJ20051037.
144. Klawitter S, Hofmann LP, Pfeilschifter J, Huwiler A (2007) Extracellular nucleotides induce migration of renal mesangial cells by upregulating sphingosine kinase-1 expression and activity. Br J Pharmacol 150(3): 271-280. doi: 10. 1038/sj. bjp. 0706983.
145. Lin CC, Lin WN, Cheng SE, Tung WH, Wang HH, Yang CM (2011) Transactivation of EGFR/PI3K/Akt involved in ATP-induced inflammatory protein expression and cell motility. J Cell Physiol. doi: 10. 1002/jcp. 22880.
146. Yu N, Erb L, Shivaji R, Weisman GA, Seye CI (2008) Binding of the P2Y2 nucleotide receptor to filamin A regulates migration of vascular smooth muscle cells. Circ Res 102(5): 581-588. doi: 10. 1161/CIRCRESAHA. 107. 162271.
147. Harada K, Matsumoto Y, Umemura K (2011) Adenosine diphosphate receptor P2Y12-mediated migration of host smooth muscle-like cells and leukocytes in the development of transplant arteriosclerosis. Transplantation 92(2): 148-154. doi: 10. 1097/TP. 0b013e318221d407.
148. Behdad A, Sun X, Khalpey Z, Enjyoji K, Wink M, Wu Y, Usheva A, Robson S (2009) Vascular smooth muscle cell expression of ectonucleotidase CD39 (ENTPD1) is required for neointimal formation in mice. Purinergic Signalling 5(3): 335-342. doi: 10. 1007/s11302-009-9158-y.
149. Burnett LA, Blais EM, Unadkat JD, Hille B, Tilley SL, Babcock DF (2010) Testicular expression of Adora3i2 in Adora3 knockout mice reveals a role of mouse A3Ri2 and human A3Ri3 adenosine receptors in sperm. J Biol Chem 285(44): 33662-33670. doi: 10. 1074/jbc. M110. 156075.
150. Rodriguez-Miranda E, Buffone MG, Edwards SE, Ord TS, Lin K, Sammel MD, Gerton GL, Moss SB, Williams CJ (2008) Extracellular adenosine 5′-triphosphate alters motility and improves the fertilizing capability of mouse sperm. Biol Reprod 79(1): 164-171. doi: 10. 1095/biolreprod. 107. 065565.